India’s rising burden of gut and metabolic disorders has pushed millions to seek solutions that go beyond temporary symptom relief. Responding to this urgent need, LONGENY—a precision-health startup focused on personalised preventive care—has launched truGut360™, an advanced gut microbiome testing solution developed with scientific support from Austria-based MyBioma. This next-generation test offers one of the most comprehensive microbiome analyses available to Indian consumers.
Uncovering the Root Causes Behind Persistent Symptoms
For years, people struggling with bloating, acidity, fatigue, PCOS symptoms, thyroid irregularities, autoimmune conditions, weight fluctuations, or chronic inflammation have had limited visibility into what drives these issues. truGut360™ fills this gap by analysing microbial diversity, inflammation markers, metabolic pathways, immune–gut interactions, digestion efficiency, and early indicators of long-term disease risk.
The Urgent Need for Deeper Diagnostics
Digestive and metabolic disorders are rising at an alarming rate: one in three Indians now experiences weekly digestive discomfort, while more than 135 million live with metabolic disease. As the demand for root-cause-driven diagnostics grows, truGut360™ provides timely, science-backed clarity.
Why the Gut Microbiome Matters More Than Ever
Scientific evidence shows that nearly 70% of the immune system and up to 90% of metabolic activity are governed by the gut microbiome. Moreover, global studies link gut dysbiosis to conditions such as obesity, PCOS, diabetes, and depression. It is also associated with hormonal imbalances, autoimmune disorders, chronic fatigue, and accelerated ageing.
>>By translating this complex science into a user-friendly system, truGut360™ offers lab-grade insights through a simple at-home sample collection and a digitally delivered precision-health report.
A New Standard for Personalised, Root-Cause–Based Preventive Care
Unlike generic wellness tests, truGut360™ uses advanced sequencing technology. Its AI-powered precision-health framework delivers clinically grounded, personalised recommendations. It provides actionable insights across:
• Personalised nutrition guidance
• Digestive and metabolic efficiency
• Immunity and inflammation reduction
• Hormonal balance support
• Energy, mood, and long-term vitality enhancement
The test goes beyond identifying imbalances—it offers a clear, evidence-backed plan to help individuals reverse them.
Expert Perspectives on the Future of Gut Health
“India is in the middle of a health crisis that most people don’t recognise. Gut dysfunction is driving everything from low energy to hormonal instability to severe metabolic disease, yet it remains invisible in routine check-ups. truGut360™ makes the invisible visible,” said Anil K.C, Founder & CEO, LONGENY. “When individuals understand what’s happening inside their gut, they finally gain the clarity and direction needed to take control of their health today.”
As per the press release, Dr. Nikolaus Gasche, Co-founder & Managing Director, MyBioma, added, “The gut microbiome is a central regulator of long-term health. With truGut360™, people across India can now access advanced microbial insights that were once limited to specialised research centres. This marks an important shift toward personalised, proactive health management.”
Empowering India’s Transition Toward Proactive Health
As chronic lifestyle and metabolic disorders rise—and as younger populations adopt preventive mindsets—truGut360™ arrives at a critical juncture. LONGENY, recognised for its work in precision diagnostics and root-cause–based health optimisation. It believes this test will be foundational. It helps individuals improve digestion, stabilise metabolism, support hormonal health, and enhance overall healthspan.